King Salmon looks to grow in Southland
NZ King Salmon could have done without an aquatic visitor during a recent tour of its Marlborough Sounds sea farms by institutional investors.
NZ King Salmon could have done without an aquatic visitor during a recent tour of its Marlborough Sounds sea farms by institutional investors.
Listed companies usually go to great lengths to avoid confrontational annual shareholder meetings.
Software developer's stock has done well since falling off cliff.
Sportspeople love pulling out the "it's been a journey" cliche when scrambling to say something profound during post-match interviews.
COMMENT: Is Rod Drury going out of his way to bite the hand that feeds him?
New Zealand's initial public offering pipeline is showing some green shoots after a quiet 18 months.
"Don't panic" has been the overall tone, as would be expected, but a wide range of views have been expressed.
COMMENT: Rakon shareholders may have been a little perplexed by the remuneration section of the technology firm's annual report, released last week.
Low interest rates have been a key factor behind the NZ sharemarket's strong run, due to its high proportion of dividend-paying, high-yielding stocks.
There's no doubting that the NZX and the wider investment community would like to see more initial public offers and sharemarket listings.
One thing is for sure - the technology that underpins Bitcoin has got stock exchanges, clearing houses, banks and central banks talking.
COMMENT: The New Zealand sharemarket has a global reputation as a lucrative source of dividends.
COMMENT: Tegel's sharemarket listing could be the most high-profile float the NZX will see this year. But the company is taking a low-key approach to its big day.
Stock Takes; Stocks with exposure to China's booming e-commerce trade have settled down after copping heavy selling.
Could newly listed health supplements maker Oceania Natural be benefiting from the Blackmores effect?
Fonterra has been copping heavy criticism over its strategy as the financial pressure facing farmer shareholders deepens.
Dick Smith, founder of the soon-to-be defunct retailer that carries his name, could have chosen better timing to have a pop at Harvey Norman.
On the face of it, Chapman Tripp's answer for assuaging market concerns stemming from the Dick Smith disaster seems sensible.
Last month's sharemarket turmoil hasn't prompted the private equity owners of Tegel Foods to chicken out of plans to take the poultry business public.
Australasian infant formula stocks have proved a pretty good bet lately.
With the year coming to a close, Stock Takes has a look at some of the sharemarket winners and losers of 2015.
Picture this. It's 5.30pm in Beijing, or possibly Shanghai. Workers are preparing to head home from the office, but the traffic is apocalyptic.
Back in August, it would have been difficult to imagine the S&P/NZX 50 notching up yet another year of double-digit returns.
Things were looking up for Intueri Education Group shareholders at the start of this month.
Kathmandu hasn't been the only company courting shareholder discontent with questionable pay proposals.
Fonterra boss Theo Spierings wasn't mincing his words this week when asked about rival Synlait Milk's moves to sell cut-price infant formula in China.
The A$30 billion combined annual cash profit reported by Australasia's big four banking giants is an eye-popping figure by anyone's measure.
The sharemarket's October dream run came to an end this week.
NZX may face the uncomfortable prospect of dropping out of its own benchmark index if its terrible share price performance doesn't improve.